[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wegro_app Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1787088114588209152.png) Wegro App [@wegro_app](/creator/twitter/wegro_app) on x 10.4K followers
Created: 2025-07-16 11:02:32 UTC

𝗚𝗹𝗲𝗻𝗺𝗮𝗿𝗸 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 𝗟𝘁𝗱: 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 𝗦𝘂𝗺𝗺𝗮𝗿𝘆

Glenmark Pharmaceuticals presented its Investor Day 2025, detailing its strategic outlook and financial goals. The presentation emphasized sustained value creation through innovation, global execution, and financial discipline.  Glenmark is focusing on becoming a leading, research-led, global pharmaceutical company.

- 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗠𝗼𝗱𝗲𝗹 & 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆:
  ▪ ~US$1.6 billion consolidated revenue. 🌍
  ▪ Over XX% revenue from branded markets.
  ▪ Presence in over XX countries.
  ▪ Key therapeutic areas: Dermatology, Respiratory, and Oncology.
  ▪ Transitioning into a pivotal stage of overall growth journey.

- 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 & 𝗣𝗶𝗽𝗲𝗹𝗶𝗻𝗲:
  ▪ >15 molecules in clinical development. 🧪
  ▪ X active partnerships for innovative products.
  ▪ Focus on Oncology & Immunology.
  ▪ Out-licensing deals for ISB 880, ISB 2001, and the OX40 portfolio.

- 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹 𝗙𝗼𝗼𝘁𝗽𝗿𝗶𝗻𝘁 & 𝗚𝗿𝗼𝘄𝘁𝗵:
  ▪ Expanding branded business in Europe & Emerging Markets.
  ▪ Growing US generic business through Respiratory & Injectables launches.
  ▪ IGI (Ichnos Glenmark Innovation) is becoming a self-sustaining biotech company. 💰

- 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹𝘀:
  ▪ Driving financial discipline & delivering shareholder value.
  ▪ Medium-term targets include 12-14% CAGR revenue growth, XX% consolidated EBITDA margin, and XX% consolidated ROCE and ROE.

- 𝗜𝗚𝗜 (𝗜𝗰𝗵𝗻𝗼𝘀 𝗚𝗹𝗲𝗻𝗺𝗮𝗿𝗸 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻):
  ▪ The ISB 2001 deal with AbbVie. 🤝
  ▪ ISB 2001: A first TREAT trispecific antibody for relapsed/refractory multiple myeloma. 🧬
  ▪ ISB 830-X8 / STAR-310: Potential first-choice for moderate-to-severe AD.
  ▪ ISB XXX / ALM27134: Viable treatment option for a progressive & debilitating disease.

📊 GLENMARK PHARMACEUTICALS LTD | 🏷️ Investor Presentation

🌐 Details:

⚡️AI-driven WhatsApp updates - Try FREE 👉


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945438897670181052/c:line.svg)

**Related Topics**
[investment](/topic/investment)

[Post Link](https://x.com/wegro_app/status/1945438897670181052)